Document Detail


Apicidin, a histone deacetylase inhibitor, induces differentiation of HL-60 cells.
MedLine Citation:
PMID:  12490313     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The fungal metabolite apicidin (cyclo(N-O-methyl-L-tryptophanyl-L-isoleucinyl-D-pipecolinyl-L-2-amino-8-oxodecanoyl)) inhibited the growth of HL-60 cells in a concentration-dependent manner (100-1000 nM). At higher concentrations (>300 nM), cell death was induced. At 100 nM, it induced hyperacetylation of histone H4 time-dependently, while trichostatin A induced transient hyperacetylation. Apicidin (10-100 nM) increased the cells having nitroblue tetrazolium-reducing activity and expressing CD11b but not CD14 and CD15. The expression of CD11b by apicidin was long lasting, while that by trichostatin A was transient. In K562 cells, apicidin at 10-100 nM did not inhibit cell growth nor express CD11b, CD14 and CD15. Our findings indicate that apicidin inhibits proliferation and induces the early stage of differentiation of HL-60 cells.
Authors:
JangJa Hong; Kenji Ishihara; Kouya Yamaki; Kenji Hiraizumi; Tadao Ohno; Jong Woong Ahn; OkPyo Zee; Kazuo Ohuchi
Related Documents :
698123 - Mutant mouse l-cells: a model for megaloblastic anaemia.
18707013 - Chromatin dynamics during the plant cell cycle.
10569183 - Role of nitric oxide in the induction of apoptosis by smokeless tobacco extract.
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Cancer letters     Volume:  189     ISSN:  0304-3835     ISO Abbreviation:  Cancer Lett.     Publication Date:  2003 Jan 
Date Detail:
Created Date:  2002-12-19     Completed Date:  2003-02-28     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  7600053     Medline TA:  Cancer Lett     Country:  Ireland    
Other Details:
Languages:  eng     Pagination:  197-206     Citation Subset:  IM    
Affiliation:
Laboratory of Pathophysiological Biochemistry, Graduate School of Pharmaceutical Sciences, Tohoku University, Aoba Aramaki, Aoba-ku, Sendai, Miyagi 980-8578, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acetylation / drug effects
Antigens, CD11b / analysis
Antigens, CD14 / analysis
Antigens, CD15 / analysis
Apoptosis / drug effects
Cell Differentiation / drug effects
Dose-Response Relationship, Drug
Enzyme Inhibitors / pharmacology*
HL-60 Cells / cytology,  drug effects*
Histone Deacetylase Inhibitors*
Histones / metabolism
Humans
K562 Cells / drug effects
Neoplasm Proteins / antagonists & inhibitors*,  metabolism
Peptides, Cyclic / pharmacology*
Protein Processing, Post-Translational / drug effects
Chemical
Reg. No./Substance:
0/Antigens, CD11b; 0/Antigens, CD14; 0/Antigens, CD15; 0/Enzyme Inhibitors; 0/Histone Deacetylase Inhibitors; 0/Histones; 0/Neoplasm Proteins; 0/Peptides, Cyclic; 0/apicidin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Plasminogen activator inhibitor-1 gene polymorphism and colorectal cancer risk and prognosis.
Next Document:  Preferential integration of a transfected marker gene into spontaneously expressed fragile sites of ...